We appreciate the interest shown in our paper and the comments of Lanka and Cummings. 1 Resuscitation of the very low birth weight infant has become complex. In addition to monitoring supplemental oxygen delivery, close attention to temperature control, the most appropriate and effective method of inflating the lung, and deciding whether to use early surfactant in the delivery room are all part of the intense attention to detail required in the early minutes following delivery. It is within this framework that we embarked on our practice plan to lower the inspired oxygen in the delivery room. In the Methods section of our paper, we clearly delineated the practice plan and one of our goals, which was to achieve saturation values of between 85-95%. This is consistent with the current Neonatal Resuscitation Program textbook, which states that 'if saturations are less than 85% and are not increasing, increase the oxygen concentration being delivered from the blender'.
2 Lanka and Cummings comment that 'a saturation goal of 85% at 3 min is rather high, particularly when measured postductally as in this study'. This is personal conjecture and is not based on any evidence that we are aware of. Lanka and Cummings comment further that 'A pre-ductal SpO2 of 85% at 5 min, or 70% at 3 min, is consistent with normal transition, and has been recommended by others'. Although this is a correct statement, the references relate to term babies. 3, 4 In this regard, in the results we state that 'In general, saturation values increased slowly to the desired range of 85 to 95% over 5 to 10 min'. We refer Lanka and Cummings to the papers of Escrig 5 and Wang 6 that describe the saturation changes with time in relation to the changes in inspired oxygen delivered. Regarding the issue of the changing oxygen requirement in the delivery room, we stated ''The admitting inspired oxygen concentration (FiO2) was lower than the initiating FiO2 in the delivery room in 16 (31%) infants; it remained the same in 12 (22%) infants and increased in 25 (47%) infants''. Individually these changes were not influenced by the starting FiO2 in the delivery room.
The decrease in pCO 2 from 53 ± 10 to 41 ± 12 during the practice plan was unanticipated. We do not have available the inflating pressures that were delivered during resuscitation. However, we have now reanalyzed our data in response to this question, which may help address the concern of a pressure effect. Thus, for those infants who were intubated in the delivery room (n ¼ 28), the pCO 2 declined from 51 ± 13 to 42 ± 13 (P ¼ 0.049) when comparing the first two with the last epochs of the practice plan. For the infants who were placed on CPAP (n ¼ 25), the pCO 2 declined from 49±9 to 42±9.5 (P ¼ 0.03) when comparing the first two with the last epochs.
Lanka and Cummings state, 'Finally, there is the question of safety. The observation that preterm infants less than 28 weeks gestation had a higher FiO2 requirement at 24 h is contrary to the conclusion that the practice plan was safe'. We caution against naïvely postulating that the safety of using less oxygen during stabilization or resuscitation in the delivery room will translate into a lower oxygen requirement at 24 h in those very low birth weight infants <28 weeks. For example there is abundant data from the many surfactant studies undertaken in larger premature infants that despite the administration of surfactant, the mean FiO2 requirement at 72 hours approximated 30% and was comparable to that of controls. 7 Interesting in the larger VLBW infant >27 weeks, the FiO2 at 24 hours was lower than the historical controls.
As we reported on the feasibility of implementing a practice plan that incorporated current authoritative recommendations, and not a randomized study of exposure-outcome relationships, it would be inappropriate to discuss the impact of our practice plan on morbidities such as bronchopulmonary dysplasia or retinopathy of prematurity. Such questions demand large randomized studies that are specifically powered to answer the specific morbidity. More importantly, there is the misconception in our opinion that by lowering supplemental oxygen in the delivery room there will be a reduction in long-term morbidity. All of us recognize the complex medical and environmental issues associated with prolonged hospitalization, including the judicious management of oxygen in the neonatal intensive care unit, nosocomial infections, and so on, all of which contribute to long-term morbidities.
Because of the complex issues involved, we had relatively straightforward goals for the practice plan. We stand by our conclusions that state: 'The data now strongly suggest that a FiO2 of considerably less than 100% can be used to initiate resuscitation in the delivery room. It appears that 30% may be a good starting concentration, provided the heart rate is rapidly increasing or greater than 100 beats per min'. The small randomized studies of Escrig 5 and Wang 6 support this observation. Finally each neonatal group has to begin to formulate a strategy to deal with the issue of the appropriate amount of inspired oxygen to deliver at birth. As long as the provider has the ability to deliver blended oxygen and uses a pulse oximeter as a guide, the delivered O 2 can be dialed up or down to achieve time-related target ranges. Provided the heart rate is good, patience becomes a virtue as the saturation values increase slowly.
